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Gastroenteritis is the most common illness requiring
admission to the paediatric wards at Baragwanath Hospital.
In 1956 over 1,000 children suffering from this illness were
admitted to the wards l and for every one admitted at least
20 others were treated in the out-patients department. It is
estimated that in 1951 every tenth child in the African
population of Johannesburg succumbed to an attack of
diarrhoea before reaching the age of one year.2 In Cape
Town, 45 % of all deaths in non-European children under
one year of age were due to gastroenteritis. 3
It was stated at one time that, in the United States and
elsewhere, most cases of diarrhoea and enteritis were due to
bacillary dysentery.4 This would appear, even today, to
apply to certain sections of the South African non-European
population. In the summer of 1954-55, shigella and salmonella
organisms were isolated from 71 (29%) of 241 consecutive
patients with gastroenteritis admitted to one of our wards. ~
The mortality rate among patients with these infections was
considerably higher than among those suffering from 'non-
specific' gastroenteritis. In an unselected series of 100
paediatric out-patients at this hospital, suffering from
gastroenteritis dUring the summer months, 23 were found to
be due to these infections.s In another investigation carried
out at this hospital, shigella and salmonella organisIllS' were
isolated from 37· 5 % of 200 consecutive paediatric admissions
for gastroenteritis.2 It was estimated that under ideal con-
ditions for investIgation. approximately 50% of all severe
cases of gastroenteritis would be shown to l:?e caused by
shigella or salmonella infection.2
In view of the high morbidity and mortality associated
with shigella and salmonella enteritis in the African population
of Johannesburg, it is of great importance to determine the
most efficacious antibiotics for the treatment of this group
of diseases. From our investigation in 1954-55, chloram-
phenicol* emerged as the most effective antibiotic for these
infections, as compared with sulphonamides and oxytetra-
eyclinet. However, chloramphenicol is expensive and has
certain side-effects and is therefore not an ideal drug for
* Used as chloromycetin (parke, Davis).
t U ed as terramycin (Pfizer).
out-patient use. In addition, we have gained the impression
over the past few years that the efficacy of chloramphenicol
against shigella and salmonella was diminishing. It was
therefore considered important to reassess the place. of this
antibiotic in the treatment of these infections, and if possible,
to find a safer and less expensive antibiotic.
MATERIAL AND METHODS
This study was done in two parts:
1. In Vitro Testing
During a 4-month period of the summer of 1957-58, all
cultures of shigella and salmonella organisms isolated from
patients in our paediatric wards and out-patients department
were subjected to in vitro sensitivity tests. The antibiotics tested
were chloramphenicol, streptomycin, neomycin, tetracycline
and sulphatriad (sulphamerazine 1 part, sulphathiazole 1·4
parts, sulphadiazine 1·4 parts). There was a total of 145
positive cultures, 92 of which were shigella organisms and
S3 were salmonella; of the shigella sub-groups, 64 were
Flexner, 13 Sonne, 8 Newcastle and 7 Schmitz. The methods
of culture and testing were as follows:
Rectal swabs were emulsified in tubes of saline and of
selenite F as soon after collection as possible. The saline
tubes were plated on 'SS' and desoxycholate citrate agar
after approximately 20 minutes, the selenites being treated in
the same way after 24 hours incubation. Suitable colonies
were picked off and finally identified biochemically and
serologically. Blood agar plates were flooded with a 24-hour
pure culture of the organism in nutrient broth, so obtaining
a uniform inoculum. Any excess fluid was poured off. The
petri dishes were then incubated at 37°e, with lids ajar
until dry. The antibiotic sensitivity discs were placed on the
surface of the plates by means of sterile forceps at intervals
of I t to 2 inches. These discs contained the antibiotics in
strengths of 50 pg. The inverted plates were then incubated
overnight at 37°C. The sensitivity of the organism was
assessed as follows: Zone of inhibition of growth less than
2 mm.-'resistant'; 2-4 mm.-' lightly sensitive'; 4-6 mm.-
'moderately sensitive'; greater than 6 mm.-'highly sensitive'.
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TABLE rn. IN VITRO ANTIBIOTIC SENSITIVITY RESULTS Of SHIGELLA
SUBGROUPS
Antibiotic employed
the great majority (80%) were highly sensitive'to chloram-
phenicol, 32-(35 %) were highly sensitive to streptomycin and
23 (25 %) were highly sensitive to neomycin. A high propor-
tion (53 % and 68 % respectively) were moderately sensitive
to streptomycin and neomycin. The sensitivity to tetracycline
was poor; 20 cultures (22 %) were resistant and only 1 was
highly sensitive to this antibiotic. 88 (96%) of the cultures
were completely resistant to sulphatriad. Analysis of the in






























































































































Concurrent with the commencement of in vitro testing,
all ward patients with shigella and salmonella enteritis were
treated with chloramphenicol (cbloromycetin palmitate) in
a dose of 40-50 mg. per lb. body weight per day, for a period
of 10 days. This was done regardless of the results shown in
the in vitro tests. In all, 56 patients with shigella dysentery
and 31 patients with salmonella enteritis, were so treated.
After in vitro testing had been carried out for about 2
months, it became apparent that streptomycin might also
be effective in shigella and salmonella infections. Thus 19
patients with shigella dysentel)' and 10 patients with sal-
monella enteritis were treated with oral streptomycin sulphate
in a dose of 40-50 mg. per lb. body weight per day, for a
period of 10 days. Streptomycin sulphate was freshly made
up out of ampoules in our dispensary on alternate days.
All the patients included in this trial were under :z- years
of age; all were very ill, 94% requiring intravenous therapy.
Relapses were assessed on the basis. of increased frequency
of stools, recurrence of pyrexia, and principally on a recur-
rence of clinical dehydration, requiring intravenous therapy.
Where relapses occurred, change of therapy was made to the
most effective antibiotic as indicated by the in vitro tests.
When each course of treatment was complete, or when
changes of treatment were made, rectal swab cultures were
repeated to ascertain whether the original infecting organism
was still present in the patient's stools. This was done
immediately after a course of therapy was complete. In
only a few cases could rectal swab cultures be repeated
several days after completion of treatment, since shortage
of hospital accommodation forced us to discharge most
patients immediately after clinical cure had been effected.
1. In Vitro Tests
The results of the in vitro tests with shigella organisms are
shown in Table I, and with salmonella organisms in Table
II. These tests show that of the 92 shigella cultures tested,
TABLE 1. IN VITRO A TIBIOTlC SE SlTIVITY RESULTS Of SHIGELLA
ORGANISMS
TABLE IT. IN VITRO ANTIBIOTIC SENSITrYlTY RESULTS Of SALMO. ELLA
ORGANISMS
Sensitivity
Ch/oram- Strepto- Neo- Tetra- Sulpha-
phenicol mycin mycin cycline triad
Highly sensitive 74 32 23 1 2
Moderately sensiti e 14 49 63 41 I
Mildly sensitive 0 4 3 30 I
Resistant 4 7 3 20 88
Sensitivity
Chloram- Strepto- eo- Tetra- Sulpha-
phenicol mycin mycin cycline triad
Highly sensitive 26 26 32 0 0
Moderately sensitive 26 25 19 3 0
Mildly sensitive 0 I I 12 0
Re istant I I I 38 53
Total o. of cases. . 92
Sonnei, Newcastle and Schmitz) show no significant
differences in sensitivity (Table III).
Of the 53 salmonella cultures tested, 32 (OO%) were highly
sensitive to neomycin and 26 (49 %) in each case were highly
sensitive to chloramphenicol and streptomycin. Most cultures
(72 %) were resistant to tetracycline and all were resistant to
sulphatriad. One culture was resistant to all the antibiotics
tested.
2. Clinical Trials
In the clinical trials (Table IV) 56 patients with shigella
infection were treated with chloramphenicol; of these, 41
patients (73 %) had an uneventful recovery on one course
of treatment; 8 patients died, all within the first 5 days of
treatment, while dehydration and electrolyte balance were
being corrected; 7 patients relapsed, but ultimately recovered.
In one patient relapse was due to staphylococcal enterocolitis
and septicaemia.
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TABLE IV.
o
CUNlCAL TRIAL (TOTAL 116 CASES)
DISCUSSION
Chloramphenicol emerged from in vitro tests as the most
potent agent against shigellae and one of the most potent
against salmonellae. These findings correlated well with
the results of the clinical trials, where 73 % and 74 % of
patients with shigella and salmonella enteritis respectively,
treated with this antibiotic, made an uneventful recovery.
These results compare well with those obtained in our
previous series dealing with similar cases. 5 Thus our fears
that chloramphenicol was losing its efficacy in patients With
these infections, was not substantiated. One case developed
a staphylococcal enterocolitis and septicaemia, but no
haematological ~omplications were seen in the 87 cases
treated with this antibiotic. This low incidence of compli-
cations of chloramphenicol therapy is a reflection of what
we have found over several years in using it in the treatment
of hundreds of cases of severe gastro-enteritis.
In vitro tests showed that the majority of shigella and
almonella cultures were sensitive to streptomycin. However,
B. GROUP TREATED ON STREPTOMYCI (29 CASES)
o. of
Infection cases Relapses Deaths Uneventful recovery
Shigella 19 7 4 8 (42%)
Salmonella 10 3 3 4 (40%)
Total 29 10 7 12 (41 %)
oral steptomycin; of these 8 (42 %) recovered uneventfully,
4 died and 7 relapsed. Relapses were treated with the anti-
biotic to which the particular infecting organism was most
sensitive by in vitro tests. In 5 of these cases the antibiotic
employed was chloramphenicol and in the other 2, neomycin.
One of the cases in which a change was made to
chloramphenicol therapy died during the course of treatment,
the others recovered.
31 patients with salmonella infection were treated with
chloramphenicol, of whom 23 (74 %) recovered uneventfully,
6 died and 2 relapsed but responded to a second course of
treatment. Deaths in this group all occurred within the first
6 days of treatment. One of the 2 patients with salmonella
infection who relapsed while on chloramphenicol therapy
was the only case in the whole series in which on rectal
swab culture an organism was found after a complete cQur§.e
of therapy. The rectal swab from this patient produced the
only culture of salmonella showing complete resistance to
chloramphenicol in vitro.
10 patients with salmonella enteritis were treated with
oral steptomycin; 4 (4O%) of these recovered uneventfully,
3 died, and 3 relapsed. Neomycin therapy was used in 2 of
the relapses and chloramphenicol in the third case. All three
recovered.
The group of patients treated with oral streptomycin
was relatively small and the trial of this antibiotic was
abandoned as it was soon -apparent that the death and relapse
rate in this group was considerably higher than in the group
treated with chloramphenicol.
the use of tbi antibiori in the clinical trials was di-
appoinung; only 42% and 40% of patients uffering fr m
shigella and alrnonella enteriti respe tively reco ered
uneventfully on treatment Wit:l it. Sangster7 found strepto-
mycin to be very efficaciou in the treatment of a large erie
of adults and children suffering from higella dysentery.
However, his cases, as contra ted with our , were not severely
ill; less than 1% required intravenous therapy for dehy-
dration. The series are thus probably not comparable. The
discrepancy between our in vitro and in vivo results with
streptomycin may be partly explained by the work of Forbes,s
who showed that in vitro streptomycin kill shigella Sonne
in lower concentration than chlortetracycline, oxytetra-
cycline or chloramphenicol, but that this organi m acquire
resistance to streptomycin earlier than to the other anti-
biotics. Brown and Bailey,9 di cu ing the use of streptomycin
in B. coli gastroenteritis in infants, also state that resistance
is rapidly acquired to this antibiotic by intestinal organisms.
In vitro tests showed that shigellae were slightly less
sensitive to neomycin than to chloramphenicol, but that
salrnonellae were more sensitive to neomycin than to any of
the other antibiotics. Neomycin was not included in the
clinical trials, but will be tested at some future time. This
antibiotic is too toxic for parenteral administration, but is not
absorbed when given orally and is afe when administered
this way. At present, it is too expensive to allow its routine
use, but it is possible that a shorter course of therapy than
we have employed in using chloramphenicol may be sufficient.
Tetracycline and its derivatives have been disappointing
in the treatment of shigella and salmonella enteritis. In our
previous series5 oxytetracycline was less effective than
chloramphenicol ill treating these infections. In the present
in vitro tests, the majority of cultures were very poorly
sensitive to tetracycline, especially the salmonellae, 72 % of
which were completely resistant to this antibiotic. These
findings have been in contrast to those of other workers10, 11
who found chlortetracycline, oxytetracycline and tetracycline
effective particularly in the shigella dysenteries.
Sulphatriad did not irIhibit the growth of shigellae and
salrnonellae in our in vitro tests, 96% and 100% of these
cultures, respectively, being completely resistant. Sulphona-
mides are still very commonly used in the treatment of
gastroenteritis, but it appears rather pointless to do so
where a high proportiCln of these cases are due to shigella
and salmonella infections, particularly in view of the not
inconsiderable toxic effects of these chemotherapeutic agents.
It thus appears from this investigation that chloromycetin
is the antibiotic of choice to the treatment of shigella and
salmonella enteritis and that neomycin warrants further
investigation in their treatment.
SUMMARY
In vitro sensitivity tests were carried out on 92 culture of
shigellae and 53 of salrnonellae, using chloramphenicol,
streptomycin, neomycin, tetracycline and sulphatriad.
The findings of the in vitro tests are contrasted with the
results of treatment of 1J6 patients with shigella and salmo-
nella enteritis, using chloramphenicol and oral treptomycin.
Chloramphenicol was effective, both in vitro and in vivo.
Streptomycin was effective ill vitro but relatively ineffective
in vivo. in vitro shigella and almonella sensitivity to neomycin
was good, but was very poor to tetracycline and ulphatriad.
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AN UNUSUAL OBSTETRIC CASE
M. SEG.u.. M.se., M.B., B.CH., Springs, Transvaal
For the onset of menstruation to be delayed until the age of 33
is most unusual; even more remarkable is the occurrence of
pregnancy 2 years later. The following is the history of this case.
Mrs. AS.T., aged 35, was first seen by me on 12 August 1958,
complaining of a haemorrhagic vaginal discharge and indigestion.
She had felt quite well until approximately 3 months previously,
when she began to suffer from heartburn and nausea. A barium-
meal examination was done, but the findings were normal. She
was able to take a light breakfast, but could only tolerate milk
for the rest of the day. Despite this restricted diet her weight
increased. In addition she had a slight haemorrhagic vaginal
discharge, which had appeared irregularly for the past few months,
but was not troubling her at the time. .
Questioned about her menstrual history she stated that she
had never menstruated until the age of 33, 2 years ago. Whilst
a student nurse she had an episode of abdominal pain which
necessitated laparotomy and she had been told that her uterus
was very underdeveloped (see below). No other pathological
condition was found. In 1956, whilst in Rhodesia, she was given
courses of stilboestrol therapy-she volunteered that this was
the drug used-taking this preparation for periods of 6 weeks,
then omitting it for 2 weeks. This she did for 18 months. Her
menses commenced during this treatment and continued after it
was stopped, lasting 3 days, with an intermenstrual period of
28-35 days. For the past few months her menses had been replaced
by the haemorrhagic discharge.
On examination, the patient, who was of average height and
slender build, was found to be approximately 24-weeks pregnant.
Speculum examination did not show any cause for the bleeding
There were also no obvious signs of endocrine dysfunction. The
information that she was pregnant came as a great surprise to
ber.
Realizing that her history, as given above, was somewhat
indefinite on certain points, I questioned her more closely, but
could elicit no clearer story-only the additional information
that she had been married twice; first at the age of 19 for a period
of 4 years, then to her present husband since 1949. An interview
was arranged with him and he corroborated her story. He is
the same age as she, of very good intelligence, holding a responsible
techuical position on a mine. The patient is of average intelligence.
The subsequent history was unfortunate. Treatment was
given for the dyspepsia and the usual antenatal care commenced.
On 23 August there was a slight vaginal haemorrhage, which
ceased the same day with rest. This recurred on 4 September,
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now associated with moderate abdominal pains. She went to
bed and called me the next day. The pains were now more severe,
the bleeding slightly more, but not alarming. She was admitted
to hospital, where on 7 September, despite fairly intensive seda-
tion, she gave birth to a live female infant, weighing 2 lb. 6 oz.
The placenta, however, did not deliver spontaneously and after
a period of waiting, with indications of possible excessive blood
loss, manual removal was carried out. As had been suspected
from the previous bleedings, it was a lateral placenta praevia.
The patient's progress was unevenrful, but the infant lived only
I week.
Comment
When my interest had been aroused by the exceptional history,
I wrote to the surgeon who had carried out the laparotomy.
He replied: 'I certainly remember Miss ... (as she then was) ...
1 found an infantile uterus, tubes and ? ovaries ... I would never
have believed pregnancy possible.'
I further addressed a letter to the Editor of The Practitioner
asking for the comment of any of the panel of experts who con-
tribute to that journal's 'Notes and Queries' section. The follow-
ing is his reply:
'Thank you for your letter. I referred tills to Or. Peter Bishop,
who is author of 'Recent Advances in Endocrinology' and prob-
ably knows more about the subject than anyone else in this country,
and this is what he says:
"I would have thought that tbis was a most unusual story
and indeed it is certainly one of which I have never heard myself
before. I know of girls who do not menstruate before 18 or 21
and then start to have perfectly regular periods.
"I do not have much faith in stilboestrol as a method of in-
ducing spontaneous cycles, and I would have thought that in
this case the stilboestrol therapy was probably not the cause of
the stimulation of the ovarian activities.
"I am afraid I do not know of any literature on this subject;
indeed I am at present engaged in writing a book on gynaeco-
logical endocrinology and I am astonished how scanty is the
literature on the subject," ,
I am extremely grateful to Dr. William A R. Thomson, Editor
of the Practitioner, London, and to Dr. Oifford Thomson, of
Johannesburg, for their very prompt and most helpful replies
to my queries about this case.
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